Dexterous Endoscopes
PrivateLast Round
Grant
Mar 17, 2026
Total Funding Raised
$927,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dexterous Endoscopes is a medical device company that develops endoscopes with variable stiffness, providing high control and advanced tissue dissection capabilities to enable new types of minimally invasive procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dexterous Endoscopes Comparables
Compare Dexterous Endoscopes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zsquare | 71% | |
| OTU Medical Inc. | 71% | |
| Karl Storz SE & Co. KG | 68% |
Dexterous Endoscopes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 17, 2026 | ||||
| Accelerator | Mar 11, 2026 | ||||
| Accelerator | Mar 11, 2026 | ||||
| Grant | Feb 26, 2026 | ||||
| Accelerator | Dec 20, 2025 | ||||
Grant | Dec 1, 2025 |
Dexterous Endoscopes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Canton of Vaud | Grant |
| HSG START Accelerator | Accelerator |
| Innosuisse | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Company is a spin-off from EPFL (École polytechnique fédérale de Lausanne).
- Mar 17, 2026
$318K grant received from Canton of Vaud.
Recent news
Latest coverage and updates
- recognized_asSep 14, 2026
At the Top100 Swiss Startup Award 2026 ceremony organized by Venturelab, Dexterous Endoscopes is named best newcomer in the Top100 Swiss Startup Ranking 2026 in Switzerland on Sep 14th '26.
- receives_awardSep 9, 2026
Dexterous Endoscopes received award BIND - BioInnovation Day Best Startup Award 2026 on Sep 9th '26.
- is_developingSep 9, 2026
Dexterous Endoscopes is developing unique endoscope on Sep 9th '26.
- receives_financingSep 9, 2026
Dexterous Endoscopes received financing of $124K in Seed on Jul 1st '25.
- recognized_asSep 8, 2026
Dexterous Endoscopes recognized as Top100 Newcomer of the Year 2026 on Jul 1st '26.
Dexterous Endoscopes Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dexterous Endoscopes's valuation, stock price, and market status.
Is Dexterous Endoscopes a public or private company?
Dexterous Endoscopes is a private company.
What is the current stock price of Dexterous Endoscopes?
Dexterous Endoscopes is a private company, so its shares have no public market price. Caplight tracks Dexterous Endoscopes's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dexterous Endoscopes worth (valuation)?
Valuation information for Dexterous Endoscopes is not publicly available.
Can I buy Dexterous Endoscopes stock?
Dexterous Endoscopes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dexterous Endoscopes's last funding round?
Dexterous Endoscopes's most recent funding round was Grant on March 17, 2026.
Who are the main investors in Dexterous Endoscopes?
Key investors in Dexterous Endoscopes include Gebert Rüf Stiftung, Canton of Vaud, HSG START Accelerator, Innosuisse, Venture Kick.
Will Dexterous Endoscopes IPO soon?
No public IPO plans have been announced for Dexterous Endoscopes.
How can I track Dexterous Endoscopes secondary market activity?
Caplight tracks bids, offers, and trades in Dexterous Endoscopes's shares on secondary markets.